These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31532082)

  • 21. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Wardlaw JM; Koumellis P; Liu M
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis safety and effectiveness in acute ischemic stroke patients with pre-morbid disability.
    Caruso P; Ajčević M; Furlanis G; Ridolfi M; Lugnan C; Cillotto T; Naccarato M; Manganotti P
    J Clin Neurosci; 2020 Feb; 72():180-184. PubMed ID: 31875830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
    Liu J; Huang J; Xu H; Dai H
    Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intravenous thrombolysis with and without salvianolic acids for injection on the functional recovery of patients with acute ischemic stroke: A systematic review, meta-analysis, and trial sequential analysis.
    Wang L; Liu Y; Wei J; Liang X; Zhang Y
    Phytother Res; 2023 Jun; 37(6):2513-2530. PubMed ID: 37092721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis.
    Donaldson L; Fitzgerald E; Flower O; Delaney A
    Emerg Med Australas; 2016 Oct; 28(5):496-510. PubMed ID: 27561375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis.
    Al-Salihi MM; Saha R; Ayyad A; Al-Jebur MS; Al-Salihi Y; Roy A; Dalal SS; Rivet D; Spiotta AM; Qureshi AI
    Clin Neurol Neurosurg; 2024 Jan; 236():108097. PubMed ID: 38176219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Kwon JH; Shin SH; Weon YC; Hwang JC; Baik SK
    Neuroradiology; 2011 Oct; 53(10):779-85. PubMed ID: 21808986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
    Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
    Liang Z; Zhang J; Huang S; Yang S; Xu L; Xiang W; Zhang M
    BMC Neurol; 2022 Jul; 22(1):280. PubMed ID: 35897006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing outcome and recanalization results in patients with anterior circulation stroke following endovascular treatment with and without a treatment with rt-PA: A single-center study.
    Al-Khaled M; Brüning T; Gottwald C; Roessler F; Royl G; Eckey T
    Brain Behav; 2018 May; 8(5):e00974. PubMed ID: 29761023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.
    Luo S; Zhuang M; Zeng W; Tao J
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke.
    Yang J; Yu F; Liu H; An H; Xiong R; Huang D
    Sci Rep; 2016 Aug; 6():31344. PubMed ID: 27510959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.